Filing Details
- Accession Number:
- 0001237899-14-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-27 17:02:26
- Reporting Period:
- 2014-08-26
- Filing Date:
- 2014-08-27
- Accepted Time:
- 2014-08-27 17:02:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1437435 | Marc Tessier-Lavigne | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-26 | 1,387 | $50.91 | 1,387 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-26 | 200 | $351.62 | 1,187 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2014-08-27 | 3,000 | $50.91 | 4,187 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-27 | 3,000 | $352.20 | 1,187 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-08-26 | 1,387 | $0.00 | 1,387 | $50.91 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-08-27 | 3,000 | $0.00 | 3,000 | $50.91 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,279 | 2021-11-18 | No | 4 | M | Direct | |
12,279 | 2021-11-18 | No | 4 | M | Direct |
Footnotes
- Represents volume-weighted average price of sales of 3,000 shares of Company stock on August 27, 2014 at prices ranging from $352.15 to $352.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2014 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.